--- # System prepended metadata title: Gastrointestinal Stent Market Growth Drivers 2034 --- According to Fortune Business Insights, the gastrointestinal stent market was valued at USD 615.8 million in 2025 and is projected to grow significantly by 2034 at a CAGR of 5.3% during the forecast period of 2026-2034. The gastrointestinal stent market is gaining momentum because healthcare providers are increasingly adopting minimally invasive procedures for the treatment of gastrointestinal obstructions and related complications. Rising geriatric populations, growing awareness regarding advanced gastrointestinal treatment options, and increasing demand for endoscopic procedures are supporting the expansion of the gastrointestinal stent market in 2026. Technological advancements in metal and biodegradable stents are further contributing to the growth of the gastrointestinal stent market. Increasing hospital admissions for gastrointestinal complications and the growing burden of digestive cancers are also creating favorable opportunities for the gastrointestinal stent market globally. Continue reading for more details: https://www.fortunebusinessinsights.com/gastrointestinal-stent-market-114932 Market Segmentation The gastrointestinal stent market is segmented based on product type, material, application, end user, and region. Based on product type, the gastrointestinal stent market is divided into biliary stents, duodenal stents, colonic stents, esophageal stents, and others. Among these, biliary stents accounted for the leading share in the gastrointestinal stent market owing to the increasing incidence of biliary obstruction and liver-related diseases. By material, the gastrointestinal stent market is segmented into metal, plastic, and others. Metal stents dominate the gastrointestinal stent market due to their improved flexibility, durability, and longer patency period. Self-expandable metallic stents are increasingly preferred in hospitals and specialty clinics because of their superior clinical outcomes. Based on application, the gastrointestinal stent market includes biliary disease, colorectal cancer, inflammatory bowel disease, gastric cancer, esophageal cancer, and others. The colorectal cancer and biliary disease segments hold a substantial share in the gastrointestinal stent market because of the growing number of gastrointestinal cancer cases worldwide. Based on end user, the gastrointestinal stent market is categorized into hospitals & ambulatory surgical centers, clinics, and others. Hospitals and ambulatory surgical centers dominate the gastrointestinal stent market owing to the high volume of gastrointestinal procedures and availability of advanced healthcare infrastructure. The growing demand for minimally invasive treatment methods is expected to strengthen every segment of the gastrointestinal stent market during 2026. Key Players Olympus Corporation Boston Scientific Corporation Medtronic Cook Medical ELLA-CS TaeWoong Medical Merit Medical Systems Becton Dickinson and Company Market Growth The gastrointestinal stent market is expected to witness strong growth during 2026 due to increasing demand for advanced gastrointestinal treatments and rising adoption of minimally invasive procedures. The increasing number of ERCP procedures worldwide is one of the primary growth drivers for the gastrointestinal stent market. Healthcare providers are increasingly preferring gastrointestinal stents because they help relieve obstructions, improve patient outcomes, and reduce hospitalization duration. The growing burden of gastrointestinal cancers, especially colorectal and esophageal cancers, is significantly contributing to gastrointestinal stent market expansion. The rapid growth in the elderly population is another major factor fueling the gastrointestinal stent market, as older adults are more susceptible to gastrointestinal complications and digestive disorders. Advancements in stent technologies, including biodegradable stents and anti-migration stents, are further improving the effectiveness of treatment procedures in the gastrointestinal stent market. Increased healthcare expenditure, improved reimbursement policies, and rising investments in gastrointestinal research are also accelerating the growth of the gastrointestinal stent market in 2026. In addition, the rising awareness regarding early diagnosis and treatment of gastrointestinal diseases is creating favorable opportunities for manufacturers operating in the gastrointestinal stent market. Restraining Factors Despite strong growth potential, the gastrointestinal stent market faces several restraining factors that may limit its expansion during the forecast period. One of the major challenges affecting the gastrointestinal stent market is the high cost associated with advanced stenting procedures and devices. Many patients in developing and underdeveloped regions have limited access to advanced gastrointestinal treatment facilities, which restricts the adoption of gastrointestinal stents. Complications associated with gastrointestinal stents, such as stent migration, bleeding, infection, perforation, and restenosis, also hamper the growth of the gastrointestinal stent market. Stringent regulatory approval processes for medical devices can delay product launches and affect innovation in the gastrointestinal stent market. In addition, the availability of alternative treatment procedures and surgical interventions may limit the adoption of gastrointestinal stents in certain patient groups. Limited awareness about advanced gastrointestinal procedures in rural areas and lack of skilled healthcare professionals are further restraining the growth of the gastrointestinal stent market. Manufacturers operating in the gastrointestinal stent market are increasingly focusing on technological innovation and strategic collaborations to overcome these challenges and strengthen their market presence. Regional Analysis North America dominated the gastrointestinal stent market in 2025 and is expected to maintain its leading position throughout 2026. The strong presence of advanced healthcare infrastructure, increasing prevalence of gastrointestinal diseases, and high adoption of minimally invasive treatment procedures are major factors supporting the gastrointestinal stent market in North America. The United States contributes significantly to the gastrointestinal stent market due to rising gastrointestinal cancer cases and growing investments in medical technology. Fortune Business Insights stated that North America accounted for a major share of the gastrointestinal stent market in 2025. Europe holds a considerable share in the gastrointestinal stent market because of increasing healthcare expenditure, growing awareness regarding digestive disorders, and rising demand for advanced endoscopic procedures. Countries such as Germany, France, and the United Kingdom are witnessing increasing adoption of gastrointestinal stents due to technological advancements in healthcare systems. The Asia Pacific region is expected to witness the fastest growth in the gastrointestinal stent market during 2026 due to the rapidly growing patient population, improving healthcare infrastructure, and increasing awareness regarding minimally invasive treatments. Countries such as China, India, and Japan are creating lucrative opportunities for the gastrointestinal stent market because of the growing incidence of colorectal cancer and gastrointestinal disorders. Rising investments by international market players and improving access to healthcare services are also supporting gastrointestinal stent market growth in the Asia Pacific region. Latin America and the Middle East & Africa are also witnessing gradual growth in the gastrointestinal stent market due to increasing healthcare modernization initiatives and rising awareness regarding gastrointestinal treatment procedures. However, limited healthcare access and economic constraints may continue to challenge the gastrointestinal stent market in these regions.